Biosimilars
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global biosimilar approvals, market entry strategies, and regulatory pathways. Gain critical intelligence for your pharmaceutical BD and investment decisions.
Showing 13–24 of 27 articles
Generic Drug Forum 2026: Key Takeaways on Market & Regulation
SAHPRA Biosimilars Approval: Pathway Analysis & Impact on Affordable Medicines
Outlook Therapeutics Completes FDA Dispute Resolution Meeting for LYTENAVA Bevacizumab Biosimilar
PANDRH Regulatory Harmonization: What You Need to Know About Biosimilar Market Entry in LATAM
US Oncology Biosimilar Landscape 2026: Pricing & Market Access Insights
Rise of Biosimilars: Market Impact Post-2026 Patent Expirations in US
COFEPRIS Biocomparables Pathway: What You Need to Know
FDA Biosimilar Substitution Policy Update: Key Regulatory Changes
FDA Approves Riabni Biosimilar: Expanding NHL Treatment Options
Biosimilar Competition Impact: US Biologics Market Analysis 2026
FDA Approves BioClone's Clone-Remicade: Cheaper Alternative to Remicade
FDA Approves Biosimilar Insulin Lispro: What You Need to Know